The report “Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic)- Global Forecast to 2027″, is projected to reach USD 3.7 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 7.9% during the forecasted period (2022 to 2027).
Browse in-depth TOC on “ Flexible Bronchoscopy Industry”
301- Tables
48- Figures
289- Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40057877
The growth in this market growth is largely driven by the rising prevalence of respiratory diseases, the growing demand for minimally invasive surgeries, growing hospital investments in bronchoscopy facilities, and technological advancements in bronchoscopes. On the other hand, the dearth of trained physicians and pulmonologists is a major challenge to the growth of this market.
“The adult patients are accounted to hold the largest share of the Flexible bronchoscopy industry, by patients in 2021.”
On the basis of patients, the bronchoscopy equipment market is segmented into adult patients and pediatric patients. The adult patients segment accounted for the larger share of the bronchoscopy equipment market in 2021. The large share of this segment can be attributed to the high image quality achieved through reusable bronchoscopes and the availability of reusable accessories.
“The hospitals are accounted to hold the largest share of the Rigid bronchoscopy market, by end users in 2021.”
Based on end users, the bronchoscopy equipment market is segmented into hospitals and ambulatory surgery centers/clinics. The hospitals segment accounted for the largest share of the bronchoscopy equipment market in 2021. The large share of this segment can be attributed to the high patient preference for hospital treatment, availability of skilled healthcare professionals, and favorable reimbursement scenario.
Inquiry Before Buying:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=40057877
“North America accounted the largest share of the bronchoscopy industry in 2021.”
The large share of the North American market can be attributed to the increasing incidence and prevalence of chronic respiratory diseases, favorable reimbursement scenario in the US, the rising incidence of lung cancer in Canada, rapid increase in healthcare expenditure, easy accessibility to advanced technologies, and the strong presence of market players in the region
The major players operating in this market are Olympus Corporation (Japan), KARL STORZ (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Ethicon (US), FUJIFILM Holdings Corporation (Japan), Medtronic (Ireland), HOYA Corporation (Japan), Richard Wolf GmbH (Germany), Cook Medical (US), Broncus Medical Inc. (China), CONMED (US), Roper Technologies (US), Teleflex Incorporated (US), Laborie Medical Technologies Corp. (Canada), EFER Endoscopy (France), EMOS Technology GmbH (Germany), VBM Medizintechnik GmbH (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), and Machida Endoscope Co., Ltd. (China)
Market Growth Drivers
- Rising prevalence of respiratory diseases
- Increasing cases of lung cancer
- Growing demand for minimally invasive surgeries
- Growing hospital investments in bronchoscopy facilities
- Technological advancements
Market Growth Opportunities
- Growing healthcare market in emerging economies
- Development of Novel Bronchoscopy Devices
- Increasing Awareness
Market Challenges
- Dearth of trained physicians and pulmonologists
- Lack of awareness among patients and healthcare providers
Key developments:
- In 2022, Ethicon, a Johnson & Johnson MedTech firm, declared today that the FDA granted 510(k) approval for its Monarch robotic surgery platform. The FDA has given Ethicon’s subsidiary Auris Health permission to use Monarch for endourological treatments. According to company representatives, it is currently the first and only versatile multispecialty robotic solution for use in both urology and bronchoscopy
- In 2022, Olympus announced the expansion of its respiratory portfolio with the launch of H-SteriScopes. In order to address the demands of infection prevention campaigns, Olympus announced the availability of its line of single-use foreign body retrieval devices, which gives doctors alternatives for a variety of purposes.
- In 2021, The EXALT Model B Single-use Bronchoscope, a single-use device intended for bedside operations in the intensive care unit, operating room, and bronchoscopy suite, received CE Mark approval
- In 2022, Olympus announced the strategic co-marketing agreement with Bracco Diagnostics Inc., which is a US subsidiary of Bracco Imaging S.p.A., a major international player in the diagnostic imaging industry. Bracco Imaging S.p.A. is a leader in the creation and delivery of new solutions for medical and surgical operations.
- In 2022, Olympus announced that its line of single-use bronchoscopes had been selected for the new Vizient Single-use Visualization Devices contract.
- In 2021, FUJIFILM Holdings Corporation announced that its complete portfolio of endoscopy and endosurgery products is available to members of Vizient.
Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=40057877
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bronchoscopes-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/bronchoscopes.asp
